FDA approves first combination tablet to treat type 2 diabetes and high cholesterol

The U.S. Food and Drug Administration has approved Juvisync (sitagliptin and simvastatin), the first combination drug to treat type 2 diabetes and high cholesterol in one tablet. Read more.

LEAVE A REPLY

Please enter your comment!
Please enter your name here